Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2019-08-01

Original market date: See footnote 1

1990-12-31

Lot number: See footnote 2

BS3078

Expiry date: See footnote 2

2014-05-31

Product name:

NEOSTIGMINE METHYLSULFATE INJECTION USP

DIN:

00874957 Electronic product monograph is not available

Company:

SANDOZ CANADA INCORPORATED
110 Rue De Lauzon
Boucherville
Quebec
Canada J4B 1E6

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intramuscular ,  Subcutaneous ,  Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

12:04.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

N07AA01 NEOSTIGMINE

Active ingredient group (AIG) number:See footnote5

0102263002

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
NEOSTIGMINE METHYLSULFATE 0.5 MG / ML
Version 4.0.3

"Page details"

Date modified: